See the DrugPatentWatch profile for clonazepam

I apologize, but the information provided does not specifically mention how Aurobindo's production methods improve clonazepam's bioavailability. However, I can provide some background on clonazepam and Aurobindo's production methods.

Clonazepam is a benzodiazepine medication used to treat panic disorder, akathisia, and certain types of seizures. Its bioavailability, which refers to the degree and rate at which a drug is absorbed into the bloodstream, is approximately 90% [1].

Aurobindo Pharma Limited is a pharmaceutical company based in India that manufactures and markets a range of generic drugs. They have a reputation for quality and have received approvals from various regulatory agencies, including the US Food and Drug Administration (FDA) [2].

While there is no specific information on how Aurobindo's production methods improve clonazepam's bioavailability, it is possible that their manufacturing processes adhere to strict quality standards, ensuring the consistent production of high-quality clonazepam tablets. Additionally, Aurobindo may employ advanced technologies or techniques to enhance the drug's solubility or stability, which could potentially impact its bioavailability [3].

However, without further information, it is not possible to provide a definitive answer to this question.

Sources:

1. [Drugs.com](https://www.drugs.com/cdi/clonazepam.html)
2. [Aurobindo Pharma Limited](https://www.aurobindo.com/)
3. [DrugPatentWatch.com](https://www.drugpatentwatch.com/patent/clonazepam-aurobindo-pharma-limited) - This source does not provide information on how Aurobindo's production methods improve clonazepam's bioavailability, but it does list patents held by Aurobindo Pharma Limited for clonazepam, which suggests their commitment to research and development in this area.